- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Accuray Incorporated (ARAY)
Accuray Incorporated stock price live, this page displays NASDAQ ARAY stock exchange data. View the ARAY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Accuray Incorporated real time stock price chart below.
What Is the Accuray Incorporated Stock Price Today?
The Accuray Incorporated stock price today is 0.281.
What Is the Stock Symbol for Accuray Incorporated?
The stock symbol for Accuray Incorporated is "ARAY."
What Stock Exchange Does Accuray Incorporated Trade On?
Accuray Incorporated is listed and trades on the NASDAQ stock exchange.
Is Accuray Incorporated a Good Stock to Buy?
Determining whether Accuray Incorporated—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARAY quote. (ISIN: US0043971052)
What Is the Accuray Incorporated Stock Price Today?
The Accuray Incorporated stock price today is 0.281.
What Is the Stock Symbol for Accuray Incorporated?
The stock symbol for Accuray Incorporated is "ARAY."
What Stock Exchange Does Accuray Incorporated Trade On?
Accuray Incorporated is listed and trades on the NASDAQ stock exchange.
Is Accuray Incorporated a Good Stock to Buy?
Determining whether Accuray Incorporated—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ARAY quote. (ISIN: US0043971052)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.257
0.305
52 wk Range
0.215
2.100
ARAY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.2570.305
52 wk Range
0.2152.100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ARAY Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Accuray Incorporated Earnings Call Summary for Q4/2026
- Accuray posted Q4 FY2026 adjusted EPS of -$0.02, beating estimates by $0.01, but revenue fell 21% YoY to $100.91M, missing forecasts by $4.91M.
- Product revenue plunged 42% in Q4 and 27% for full year, with ~$58M decline attributed to China geopolitical tensions and tariff uncertainty.
- Gross margin improved to 34.8% from 30.6% YoY; service revenue grew 6% in Q4, covering nearly 90% of active installed base with better profitability.
- Management withheld FY2027 guidance due to geopolitical risks but expects $15M in annualized cost savings and continued service revenue growth.
- TCW transaction converts $40M debt to preferred equity, providing covenant holiday through Dec 2027; stock down 79% over past year to $0.295.
Last Updated: 2026-08-19, 05:18 p/m
Read Full TranscriptEarnings
Latest Release
Aug 19, 2026
EPS / Forecast
-0.02 / -0.03
Revenue / Forecast
100.91M / 105.82M
Compare ARAY to Peers and Sector
Metrics to compare | ARAY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipARAYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | 8.7x | −0.3x | |
PEG Ratio | 0.00 | 0.11 | 0.00 | |
Price/Book | 0.8x | 2.4x | 2.6x | |
Price / LTM Sales | 0.1x | 1.8x | 3.0x | |
Upside (Analyst Target) | 31.1% | 77.7% | 58.6% | |
Fair Value Upside | Unlock | 21.5% | 8.4% | Unlock |
Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, a tailored helical solution, which integrates radiation treatment planning, delivery, imaging, and data management; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Accuray (ARAY) Stock Price Today?
The Accuray stock price today is 0.281 USD.
What Stock Exchange Does Accuray Trade On?
Accuray is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Accuray?
The stock symbol for Accuray is "ARAY."
What Is the Accuray Market Cap?
As of today, Accuray market cap is 31.910M USD.
What Is Accuray's Earnings Per Share (TTM)?
The Accuray EPS (TTM) is -0.401.
When Is the Next Accuray Earnings Date?
Accuray will release its next earnings report on Nov 11, 2026.
From a Technical Analysis Perspective, Is ARAY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Accuray Stock Split?
Accuray has split 0 times.
How Many Employees Does Accuray Have?
Accuray has 809 employees.
What is the current trading status of Accuray (ARAY)?
As of Oct 03, 2026, Accuray (ARAY) is trading at a price of 0.281 USD, with a previous close of 0.281 USD. The stock has fluctuated within a day range of 0.257 USD to 0.305 USD, while its 52-week range spans from 0.215 USD to 2.100 USD.
What Is the ARAY Premarket Price?
ARAY's last pre-market stock price is 0.260 USD. The pre-market share volume is 124,850.000, and the stock has decreased by -0.007, or -2.620%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.